volagidemab

volagidemab · REMD Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for volagidemab, covering 2025-06-03 to 2025-06-03. Get the full timeline:

Most recent: Clinical Trial Update: Glucagon Rescue of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes Treated With Volagidemab [Phase 1]